ACP2 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP1-74241
Key Product Details
Species Reactivity
Rat
Applications
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Concentration
0.5 mg/ml
Product Specifications
Immunogen
Synthetic peptides corresponding to the middle region of Acp2. Immunizing peptide sequence GQALRQRYHGFLNASYHRQEVYVRSTDFDRTLMSAEANLAGLFPPTEVQH. The peptide sequence for this immunogen was taken from within the described region.
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Description
The addition of 50% glycerol is optional for those storing this antibody at -20C and not aliquoting smaller units. However, please note that glycerol may interrupt some downstream antibody applications and should be added with caution.
Scientific Data Images for ACP2 Antibody
![Western Blot: ACP2 Antibody [NBP1-74241]](https://resources.bio-techne.com/images/products/ACP2-Antibody-Western-Blot-NBP1-74241-img0001.jpg "Western Blot: ACP2 Antibody [NBP1-74241]")
Western Blot: ACP2 Antibody [NBP1-74241]
Western Blot: ACP2 Antibody [NBP1-74241] - Mouse Kidney Lysate, Antibody Titration is 1 ug/ml and Gel concentration used is 12%Applications for ACP2 Antibody
Application
Recommended Usage
Western Blot
1.0 ug/ml
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, 2% Sucrose
Preservative
0.09% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: ACP2
Alternate Names
acid phosphatase 2, lysosomal, EC 3.1.3.2, LAP, lysosomal acid phosphatase
Gene Symbol
ACP2
UniProt
Additional ACP2 Products
Product Documents for ACP2 Antibody
Product Specific Notices for ACP2 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...